Sudeep Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0QPI01025
  • NSEID: SUDEEPPHRM
  • BSEID: 544619
INR
1,192.30
-20.55 (-1.69%)
BSENSE

Nov 20

BSE+NSE Vol: 1.27 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Corona Remedies
Akums Drugs
Marksans Pharma
Caplin Point Lab
Sudeep Pharma
Astrazeneca Phar
Viyash Scientifi
Concord Biotech
Jubilant Pharmo
Natco Pharma
Symbiotec Pharma
Why is Sudeep Pharma Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 18.30% and Operating profit at 9.53% over the last 5 years
2
Flat results in Sep 26
  • INTEREST(Q) Highest at Rs 2.81 cr
3
With ROE of 19.7, it has a Very Expensive valuation with a 14 Price to Book Value
4
Majority shareholders : Promoters
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Sudeep Pharma should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
18.30%
EBIT Growth (5y)
9.53%
EBIT to Interest (avg)
26.52
Debt to EBITDA (avg)
0.75
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.63
Tax Ratio
24.48%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
16.98%
ROCE (avg)
23.92%
ROE (avg)
19.67%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
71
Industry P/E
40
Price to Book Value
14.04
EV to EBIT
57.86
EV to EBITDA
53.91
EV to Capital Employed
13.10
EV to Sales
19.04
PEG Ratio
NA
Dividend Yield
0.13%
ROCE (Latest)
22.64%
ROE (Latest)
19.67%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
Bollinger Bands
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
NET SALES(Q)

Highest at Rs 196.70 cr

PBDIT(Q)

Highest at Rs 73.24 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 37.23%

PBT LESS OI(Q)

Highest at Rs 65.05 cr.

PAT(Q)

Highest at Rs 51.45 cr.

-10What is not working for the Company
INTEREST(Q)

Highest at Rs 2.81 cr

Loading Valuation Snapshot...
Here's what is working for Sudeep Pharma
Net Sales - Quarterly
Highest at Rs 196.70 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 73.24 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 37.23%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 65.05 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 65.05 cr has Grown at 24.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 52.35 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 51.45 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Here's what is not working for Sudeep Pharma
Interest - Quarterly
At Rs 2.81 cr has Grown at 36.41%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Interest - Quarterly
Highest at Rs 2.81 cr
in the last five quarters and Increased by 36.41 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)